Spain · Delayed Price · Currency is EUR Biotechnology Assets Statistics
Total Valuation
BME:BST has a market cap or net worth of EUR 14.71 million. The enterprise value is 15.79 million.
| Market Cap | 14.71M |
| Enterprise Value | 15.79M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
BME:BST has 75.07 million shares outstanding.
| Current Share Class | 75.07M |
| Shares Outstanding | 75.07M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.10% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.46 |
| PB Ratio | 2.20 |
| P/TBV Ratio | 2.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.40, with a Debt / Equity ratio of 0.25.
| Current Ratio | 1.40 |
| Quick Ratio | 1.40 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.61 |
Financial Efficiency
Return on equity (ROE) is -28.25% and return on invested capital (ROIC) is -12.78%.
| Return on Equity (ROE) | -28.25% |
| Return on Assets (ROA) | -4.53% |
| Return on Invested Capital (ROIC) | -12.78% |
| Return on Capital Employed (ROCE) | -9.98% |
| Weighted Average Cost of Capital (WACC) | 14.81% |
| Revenue Per Employee | 131,986 |
| Profits Per Employee | -73,695 |
| Employee Count | 26 |
| Asset Turnover | 0.24 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BME:BST has paid 319,968 in taxes.
| Income Tax | 319,968 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.01% in the last 52 weeks. The beta is 2.10, so BME:BST's price volatility has been higher than the market average.
| Beta (5Y) | 2.10 |
| 52-Week Price Change | -46.01% |
| 50-Day Moving Average | 0.21 |
| 200-Day Moving Average | 0.22 |
| Relative Strength Index (RSI) | 45.71 |
| Average Volume (20 Days) | 164,917 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:BST had revenue of EUR 3.43 million and -1.92 million in losses.
| Revenue | 3.43M |
| Gross Profit | 3.17M |
| Operating Income | -1.03M |
| Pretax Income | -1.60M |
| Net Income | -1.92M |
| EBITDA | -100,433 |
| EBIT | -1.03M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 666,218 in cash and 1.74 million in debt, with a net cash position of -1.08 million or -0.01 per share.
| Cash & Cash Equivalents | 666,218 |
| Total Debt | 1.74M |
| Net Cash | -1.08M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 6.96M |
| Book Value Per Share | n/a |
| Working Capital | 1.32M |
Cash Flow
In the last 12 months, operating cash flow was -13,110 and capital expenditures -1,984, giving a free cash flow of -15,094.
| Operating Cash Flow | -13,110 |
| Capital Expenditures | -1,984 |
| Depreciation & Amortization | 926,548 |
| Net Borrowing | -1.13M |
| Free Cash Flow | -15,094 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 92.52%, with operating and profit margins of -29.93% and -55.84%.
| Gross Margin | 92.52% |
| Operating Margin | -29.93% |
| Pretax Margin | -46.53% |
| Profit Margin | -55.84% |
| EBITDA Margin | -2.93% |
| EBIT Margin | -29.93% |
| FCF Margin | n/a |
Dividends & Yields
BME:BST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -12.51% |
| FCF Yield | -0.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:BST has an Altman Z-Score of -8.04 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.04 |
| Piotroski F-Score | 5 |